Nazlican Buyukyurt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nazlican Buyukyurt has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ayca Arslan
Faculty of Medicine, Department of Cardiology, Kafkas University, Kars, Turkey
1 shared publication - Dogan Ilis
Department of Cardiology, Kafkas University School of Medicine, Kars, Turkey
1 shared publication - Emrah Kaya
Department of Cardiology, Faculty of Medicine, Kütahya Health Sciences University, Evliya Çelebi Campus, Tavşanlı Yolu 10. km, Kütahya 43100, Türkiye
1 shared publication - Ibrahim Rencuzogullari
Department of Cardiology, Kafkas University School of Medicine, Kars, Turkey
1 shared publication - Inanc Artac
Kafkas University
1 shared publication - Mahsum Aykal
Department of Internal Medicine, Siverek State Hospital, Sanliurfa, Türkiye
1 shared publication
Latest Publications
- Open Access
- 6 February 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
The role of nitric oxide in hypertensive target organ damage in patients without renal impairment: insights from left ventricular global longitudinal strain and albuminuria
Background: Hypertension (HT) is a prevalent chronic condition that contributes significantly to morbidity and mortality by leading to target organ damage. Although nitric oxide (NO) underpins endothelial function and has been implicated in several cardiovascular conditions, its association with subclinical hypertension-mediated organ damage remains unclear. This study aimed to investigate the relationship between nitrite/nitrate (NOx)—an indirect index of NO pathways and subclinical myocardial and renal dysfunction in patients with HT. Methods: This study prospectively screened 433 adult hypertensive patients, of whom 400 were included in a cross-sectional analysis after exclusion of conditions potentially confounding cardiac or renal assessment, including end-stage renal disease requiring dialysis. All participants underwent transthoracic echocardiography to assess ventricle functions using left ventricular global longitudinal strain (LV-GLS) and provided a spot urine sample for the measurement of the urine albumin/creatinine ratio (UACR). In addition to NOx levels, inducible and endothelial nitric oxide synthase levels were evaluated from participants’ blood samples. Results: NOx levels were significantly associated with reduced LV-GLS and higher UACR values. In multivariate analysis, lower NOx levels were independently associated with impaired LV-GLS (OR: 0.817; 95% CI: 0.783–0.853; p < 0.001) and albuminuria (OR: 0.905; 95% CI: 0.877–0.934; p < 0.001). Conclusions: NOx may represent an independent biochemical parameter associated with subclinical myocardial and renal dysfunction in patients with HT.
- 6 February 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessThe role of nitric oxide in hypertensive target organ damage in patients without renal impairment: insights from left ventricular global longitudinal strain and albuminuria
Background: Hypertension (HT) is a prevalent chronic condition that contributes significantly to morbidity and mortality by leading to target organ damage. Although nitric oxide (NO) underpins endothelial function and has been implicated in several cardiovascular conditions, its association with subclinical hypertension-mediated organ damage remains unclear. This study aimed to investigate the relationship between nitrite/nitrate (NOx)—an indirect index of NO pathways and subclinical myocardial and renal dysfunction in patients with HT. Methods: This study prospectively screened 433 adult hypertensive patients, of whom 400 were included in a cross-sectional analysis after exclusion of conditions potentially confounding cardiac or renal assessment, including end-stage renal disease requiring dialysis. All participants underwent transthoracic echocardiography to assess ventricle functions using left ventricular global longitudinal strain (LV-GLS) and provided a spot urine sample for the measurement of the urine albumin/creatinine ratio (UACR). In addition to NOx levels, inducible and endothelial nitric oxide synthase levels were evaluated from participants’ blood samples. Results: NOx levels were significantly associated with reduced LV-GLS and higher UACR values. In multivariate analysis, lower NOx levels were independently associated with impaired LV-GLS (OR: 0.817; 95% CI: 0.783–0.853; p < 0.001) and albuminuria (OR: 0.905; 95% CI: 0.877–0.934; p < 0.001). Conclusions: NOx may represent an independent biochemical parameter associated with subclinical myocardial and renal dysfunction in patients with HT.